Hernyák, M.; Tóth, L.I.; Csiha, S.; Molnár, Á.; Lőrincz, H.; Paragh, G.; Harangi, M.; Sztanek, F.
Kallistatin as a Potential Marker of Therapeutic Response During Alpha-Lipoic Acid Treatment in Diabetic Patients with Sensorimotor Polyneuropathy. Int. J. Mol. Sci. 2024, 25, 13276.
https://doi.org/10.3390/ijms252413276
AMA Style
Hernyák M, Tóth LI, Csiha S, Molnár Á, Lőrincz H, Paragh G, Harangi M, Sztanek F.
Kallistatin as a Potential Marker of Therapeutic Response During Alpha-Lipoic Acid Treatment in Diabetic Patients with Sensorimotor Polyneuropathy. International Journal of Molecular Sciences. 2024; 25(24):13276.
https://doi.org/10.3390/ijms252413276
Chicago/Turabian Style
Hernyák, Marcell, László Imre Tóth, Sára Csiha, Ágnes Molnár, Hajnalka Lőrincz, György Paragh, Mariann Harangi, and Ferenc Sztanek.
2024. "Kallistatin as a Potential Marker of Therapeutic Response During Alpha-Lipoic Acid Treatment in Diabetic Patients with Sensorimotor Polyneuropathy" International Journal of Molecular Sciences 25, no. 24: 13276.
https://doi.org/10.3390/ijms252413276
APA Style
Hernyák, M., Tóth, L. I., Csiha, S., Molnár, Á., Lőrincz, H., Paragh, G., Harangi, M., & Sztanek, F.
(2024). Kallistatin as a Potential Marker of Therapeutic Response During Alpha-Lipoic Acid Treatment in Diabetic Patients with Sensorimotor Polyneuropathy. International Journal of Molecular Sciences, 25(24), 13276.
https://doi.org/10.3390/ijms252413276
